Neuroendocrine-immune interactions: Implications for health and behavior

Hormones, Brain and Behavior Online

Volumn , Issue , 2009, Pages 2597-2634

  Pace, T W W ^a   Raison, C L ^a   Miller, A H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acquired immune system; Acute stress; Chronic stress; Cytokines; Endocrine system; Glucocorticoid receptor; Hypothalamic pituitary adrenal axis; Immunotherapy; Inflammation; Innate immune system; Major depression; NF B; Sympathetic nervous system

Indexed keywords

EID: 84884763169     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008088783-8.00083-8     Document Type: Chapter

References (220)

1. Abbas A.K., Lichtman A.H. Cellular and Molecular Immunology 2003, Saunders, Philadelphia, PA. 5th edn.
2. Aggarwal B.B., Shishodia S., Sandur S.K., Pandey M.K., Sethi G. Inflammation and cancer: How hot is the link?. Biochemical Pharmacology 2006, 72:1605-1621.
3. Alesci S., Martinez P.E., Kelkar S., et al. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: Clinical implications. Journal of Clinical Endocrinology and Metabolism 2005, 90:2522-2530.
4. Anker S.D., Ponikowski P.P., Clark A.L., et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. European Heart Journal 1999, 20:683-693.
5. Baigent S.M. Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response. Peptides 2001, 22:809-820.
6. Barrientos R.M., Sprunger D.B., Campeau S., Higgins E.A., Watkins L.R., Rudy J.W., Maier S.F. Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist. Neuroscience 2003, 121:847-853.
7. Bartrop R.W., Luckhurst E., Lazarus L., Kiloh L.G., Penny R. Depressed lymphocyte function after bereavement. Lancet 1977, 1:834-836.
8. Ben-Menachem-Zidon O., Goshen I., Kreiesl T., Ben-Menahem Y., Reinhartz E., Ben-Hur T., Yirmiya R. Intrahippocampal transplantation of transgenic neural precursor cells overexpressing interleukin-1 receptor antagonist blocks chronic isolation-induced impairment in memory and neurogenesis. Neuropsychopharmacology 2007, 33:2251-2262.
9. Benschop R.J., Geenen R., Mills P.J., et al. Cardiovascular and immune responses to acute psychological stress in young and old women: A meta-analysis. Psychosomatic Medicine 1998, 60:290-296.
10. Benschop R.J., Jacobs R., Sommer B., Schurmeyer T.H., Raab J.R., Schmidt R.E., Schedlowski M. Modulation of the immunologic response to acute stress in humans by beta-blockade or benzodiazepines. FASEB Journal 1996, 10:517-524.
11. Benschop R.J., Rodriguez-Feuerhahn M., Schedlowski M. Catecholamine-induced leukocytosis: Early observations, current research, and future directions. Brain, Behavior, and Immunity 1996, 10:77-91.
12. Berkenbosch F., Wolvers D.A., Derijk R. Neuroendocrine and immunological mechanisms in stress-induced immunomodulation. Journal of Steroid Biochemistry and Molecular Biology 1991, 40:639-647.
13. Beutler B. Innate immunity: An overview. Molecular Immunology 2004, 40:845-859.
14. Bierhaus A., Humpert P.M., Nawroth P.P. NF-kappaB as a molecular link between psychosocial stress and organ dysfunction. Pediatric Nephrology 2004, 19:1189-1191.
15. Blalock J.E., Smith E.M. Conceptual development of the immune system as a sixth sense. Brain, Behavior, and Immunity 2007, 21:23-33.
16. Bluthe R.M., Dantzer R., Kelley K.W. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Research 1992, 573:318-320.
17. Borella P., Bargellini A., Rovesti S., Pinelli M., Vivoli R., Solfrini V., Vivoli G. Emotional stability, anxiety, and natural killer activity under examination stress. Psychoneuroendocrinology 1999, 24:613-627.
18. Bouman A., Heineman M.J., Faas M.M. Sex hormones and the immune response in humans. Human Reproduction Update 2005, 11:411-423.
19. Brady L.S., Lynn A.B., Herkenham M., Gottesfeld Z. Systemic interleukin-1 induces early and late patterns of c-fos mRNA expression in brain. Journal of Neuroscience 1994, 14:4951-4964.
20. Broug-Holub E., Persoons J.H., Schornagel K., Mastbergen S.C., Kraal G. Effects of stress on alveolar macrophages: A role for the sympathetic nervous system. American Journal of Respiratory Cell and Molecular Biology 1998, 19:842-848.
21. Brydon L., Edwards S., Mohamed-Ali V., Steptoe A. Socioeconomic status and stress-induced increases in interleukin-6. Brain, Behavior, and Immunity 2004, 18:281-290.
22. Brydon L., Harrison N.A., Walker C., Steptoe A., Critchley H.D. Peripheral inflammation is associated with altered substancia nigra activity and psychomotor slowing in humans. Biological Psychiatry 2008, 63:1022-1029.
23. Burns V.E., Carroll D., Drayson M., Whitham M., Ring C. Life events, perceived stress and antibody response to influenza vaccination in young, healthy adults. Journal of Psychosomatic Research 2003, 55:569-572.
24. Burns V.E., Drayson M., Ring C., Carroll D. Perceived stress and psychological well-being are associated with antibody status after meningitis C conjugate vaccination. Psychosomatic Medicine 2002, 64:963-970.
25. Buske-Kirschbaum A., Kern S., Ebrecht M., Hellhammer D.H. Altered distribution of leukocyte subsets and cytokine production in response to acute psychosocial stress in patients with psoriasis vulgaris. Brain, Behavior, and Immunity 2007, 21:92-99.
26. Capuron L., Gumnick J.F., Musselman D.L., Lawson D.H., Reemsnyder A., NemeroffC.B., Miller A.H. Neurobehavioral effects of interferon-alpha in cancer patients: Phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 2002, 26:643-652.
27. Capuron L., Pagnoni G., Demetrashvili M., Woolwine B.J., NemeroffC.B., Berns G.S., Miller A.H. Anterior cingulate activation and error processing during interferon-alpha treatment. Biological Psychiatry 2005, 58:190-196.
28. Capuron L., Pagnoni G., Demetrashvili M.F., et al. Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology 2007, 32:2384-2392.
29. Chaplin D.D. Overview of the human immune response. Journal of Allergy and Clinical Immunology 2006, 117:S430-S435.
30. Chapman K.E., Coutinho A., Gray M., Gilmour J.S., Savill J.S., Seckl J.R. Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response. Annals of the New York Academy of Sciences 2006, 1088:265-273.
31. Cohen S., Doyle W.J., Skoner D.P., Rabin B.S., Gwaltney J.M. Social ties and susceptibility to the common cold. (see comments). Journal of the American Medical Association 1997, 277:1940-1944.
32. Cover H., Irwin M. Immunity and depression: Insomnia, retardation, and reduction of natural killer cell activity. Journal of Behavioral Medicine 1994, 17:217-223.
33. Cowles M.K., Miller A.H. Stress, cytokines and depressive illness. Encyclopedia of Neuroscience 2008, 519-527. Academic Press, Oxford. L.R. Squire (Ed.).
34. Croiset G., Heijnen C.J., de Wied D. Passive avoidance behavior, vasopressin and the immune system. A link between avoidance latency and immune response. Neuroendocrinology 1990, 51:156-161.
35. Cunnick J.E., Lysle D.T., Kucinski B.J., Rabin B.S. Evidence that shock-induced immune suppression is mediated by adrenal hormones and peripheral beta-adrenergic receptors. Pharmacology, Biochemistry and Behavior 1990, 36:645-651.
36. Cunningham A.J., Edmonds C.V., Jenkins G.P., Pollack H., Lockwood G.A., Warr D. A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psycho-Oncology 1998, 7:508-517.
37. Danese A., Moffitt T.E., Pariante C.M., Ambler A., Puoulton R., Caspi A. Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Archives of General Psychiatry 2008, 65:409-415.
38. Danese A., Pariante C.M., Caspi A., Taylor A., Poulten R. Childhood maltreatment predicts adult inflammation in a life-course study. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:1319-1324.
39. Dantzer R. Cytokine, sickness behavior, and depression. Neurologic Clinics 2006, 24:441-460.
40. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: When the immune system subjugates the brain. Nature Reviews Neuroscience 2008, 9:46-56.
41. Davidson R.J., Kabat-Zinn J., Schumacher J., et al. Alterations in brain and immune function produced by mindfulness meditation. Psychosomatic Medicine 2003, 65:564-570.
42. Deak T., Nguyen K.T., Fleshner M., Watkins L.R., Maier S.F. Acute stress may facilitate recovery from a subcutaneous bacterial challenge. Neuroimmunomodulation 1999, 6:344-354.
43. DeVries A.C., Craft T.K., Glasper E.R., Neigh G.N., Alexander J.K. 2006 Curt P. Richter award winner: Social influences on stress responses and health. Psychoneuroendocrinology 2007, 32:587-603.
44. Dhabhar F.S. Stress, leukocyte trafficking, and the augmentation of skin immune function. Annals of the New York Academy of Sciences 2003, 992:205-217.
45. Dhabhar F.S., McEwen B.S. Enhancing versus suppressive effects of stress hormones on skin immune function. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:1059-1064.
46. Dhabhar F.S., Satoskar A.R., Bluethmann H., David J.R., McEwen B.S. Stress-induced enhancement of skin immune function: A role for gamma interferon. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:2846-2851.
47. Dheen S.T., Kaur C., Ling E.A. Microglial activation and its implications in the brain diseases. Current Medicinal Chemistry 2007, 14:1189-1197.
48. Dopp J.M., Miller G.E., Myers H.F., Fahey J.L. Increased natural killer-cell mobilization and cytotoxicity during marital conflict. Brain, Behavior, and Immunity 2000, 14:10-26.
49. Dunn A.J., Wang J., Ando T. Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Advances in Experimental Medicine and Biology 1999, 461:117-127.
50. Edelman S., Lemon J., Bell D.R., Kidman A.D. Effects of group CBT on the survival time of patients with metastatic breast cancer. Psycho-Oncology 1999, 8:474-481.
51. Edwards K.M., Burns V.E., Reynolds T., Carroll D., Drayson M., Ring C. Acute stress exposure prior to influenza vaccination enhances antibody response in women. Brain, Behavior, and Immunity 2006, 20:159-168.
52. Engler H., Bailey M.T., Engler A., Stiner-Jones L.M., Quan N., Sheridan J.F. Interleukin-1 receptor type 1-deficient mice fail to develop social stress-associated glucocorticoid resistance in the spleen. Psychoneuroendocrinology 2008, 33:108-117.
53. Ericsson A., Kovacs K.J., Sawchenko P.E. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. Journal of Neuroscience 1994, 14:897-913.
54. Fawzy F.I., Fawzy N.W., Hyun C.S., ElashoffR., Guthrie D., Fahey J.L., Morton D.L. Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Archives of General Psychiatry 1993, 50:681-689.
55. Fleshner M., Nguyen K.T., Cotter C.S., Watkins L.R., Maier S.F. Acute stressor exposure both suppresses acquired immunity and potentiates innate immunity. American Journal of Physiology 1998, 275:R870-R878.
56. Frank M.G., WieselerFrank J.L., Hendricks S.E., Burke W.J., Johnson D.R. Age at onset of major depressive disorder predicts reductions in NK cell number and activity. Journal of Affective Disorders 2002, 71:159-167.
57. Frenois F., Moreau M., O'Connor J., et al. Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 2007, 32:516-531.
58. Glaser R., Kiecolt-Glaser J.K. Chronic stress modulates the virus-specific immune response to latent herpes simplex virus type 1. Annals of Behavioral Medicine 1997, 19:78-82.
59. Glaser R., Kiecolt-Glaser J.K. Stress-associated immune modulation: Relevance to viral infections and chronic fatigue syndrome. American Journal of Medicine 1998, 105:35S-42S.
60. Glaser R., Kiecolt-Glaser J.K., Marucha P.T., MacCallum R.C., Laskowski B.F., Malarkey W.B. Stress-related changes in proinflammatory cytokine production in wounds. Archives of General Psychiatry 1999, 56:450-456.
61. Gordon T.P., Gust D.A., Wilson M.E., Ahmed-Ansari A., Brodie A.R., McClure H.M. Social separation and reunion affects immune system in juvenile rhesus monkeys. Physiology and Behavior 1992, 51:467-472.
62. Grippo A.J., Francis J., Beltz T.G., Felder R.B., Johnson A.K. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiology and Behavior 2005, 84:697-706.
63. Gust D.A., Gordon T.P., Brodie A.R., McClure H.M. Effect of companions in modulating stress associated with new group formation in juvenile rhesus macaques. Physiology and Behavior 1996, 59:941-945.
64. Gust D.A., Gordon T.P., Wilson M.E., Brodie A.R., Ahmed-Ansari A., McClure H.M. Removal from natal social group to peer housing affects cortisol levels and absolute numbers of T cell subsets in juvenile rhesus monkeys. Brain, Behavior, and Immunity 1992, 6:189-199.
65. Haack M., Hinze-Selch D., Fenzel T., Kraus T., Kuhn M., Schuld A., Pollmacher T. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: Effects of confounding factors and diagnosis. Journal of Psychiatric Research 1999, 33:407-418.
66. Harbige L.S. Dietary n-6 and n-3 fatty acids in immunity and autoimmune disease. Proceedings of the Nutrition Society 1998, 57:555-562.
67. Heim C., Ehlert U., Hellhammer D.H. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000, 25:1-35.
68. Heim C., Newport D.J., Bonsall R., Miller A.H., NemeroffC.B. Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. (see comment). American Journal of Psychiatry 2001, 158:575-581.
69. Heim C., Plotsky P.M., NemeroffC.B. Importance of studying the contributions of early adverse experience to neurobiological findings in depression. Neuropsychopharmacology 2004, 29:641-648.
70. Hellstrand K., Hermodsson S., Strannegard O. Evidence for a beta-adrenoceptor-mediated regulation of human natural killer cells. Journal of Immunology 1985, 134:4095-4099.
71. Helmreich D.L., Watkins L.R., Deak T., Maier S.F., Akil H., Watson S.J. The effect of stressor controllability on stress-induced neuropeptide mRNA expression within the paraventricular nucleus of the hypothalamus. Journal of Neuroendocrinology 1999, 11:121-128.
72. Hench P.S. The reversibility of certain rheumatic and non-rheumatic conditions by the use of cortisone or of the pituitary adrenocorticotropic hormone. Annals of Internal Medicine 1952, 36:1-25.
73. Hennebold J.D., Ryu S.Y., Mu H.H., Galbraith A., Daynes R.A. 11 Beta-hydroxysteroid dehydrogenase modulation of glucocorticoid activities in lymphoid organs. American Journal of Physiology 1996, 270:R1296-R1306.
74. Herbert T.B., Cohen S. Depression and immunity: A meta-analytic review. Psychological Bulletin 1993, 113:472-486.
75. Herbert T.B., Cohen S. Stress and immunity in humans: A meta-analytic review. Psychosomatic Medicine 1993, 55:364-379.
76. Hickie I., Lloyd A. Are cytokines associated with neuropsychiatric syndromes in humans?. International Journal of Immunopharmacology 1995, 17:677-683.
77. Holmes M.C., Yau J.L., Kotelevtsev Y., Mullins J.J., Seckl J.R. 11 Beta-hydroxysteroid dehydrogenases in the brain: Two enzymes two roles. Annals of the New York Academy of Sciences 2003, 1007:357-366.
78. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000, 23:477-501.
79. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocrine Reviews 1996, 17:187-205.
80. Inui A. Cancer anorexia-cachexia syndrome: Are neuropeptides the key?. Cancer Research 1999, 59:4493-4501.
81. Irusen E., Matthews J.G., Takahashi A., Barnes P.J., Chung K.F., Adcock I.M. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: Role in steroid-insensitive asthma. Journal of Allergy and Clinical Immunology 2002, 109:649-657.
82. Irwin M. Brain corticotropin-releasing hormone- and interleukin-1 beta-induced suppression of specific antibody production. Endocrinology 1993, 133:1352-1360.
83. Irwin M. Immune correlates of depression. Advances in Experimental Medicine and Biology 1999, 461:1-24.
84. Irwin M., Hauger R.L., Brown M., Britton K.T. CRF activates autonomic nervous system and reduces natural killer cytotoxicity. American Journal of Physiology 1988, 255:R744-R747.
85. Irwin M., Smith T.L., Gillin J.C. Electroencephalographic sleep and natural killer activity in depressed patients and control subjects. Psychosomatic Medicine 1992, 54:10-21.
86. Irwin M.R., Miller A.H. Depressive disorders and immunity: 20 Years of progress and discovery. Brain, Behavior, and Immunity 2007, 21:374-383.
87. Isowa T., Ohira H., Murashima S. Immune, endocrine and cardiovascular responses to controllable and uncontrollable acute stress. Biological Psychology 2006, 71:202-213.
88. Jessop D.S., Harbuz M.S., Snelson C.L., Dayan C.M., Lightman S.L. An antisense oligodeoxynucleotide complementary to corticotropin-releasing hormone mRNA inhibits rat splenocyte proliferation in vitro. Journal of Neuroimmunology 1997, 75:135-140.
89. Johnson J.D., Campisi J., Sharkey C.M., Kennedy S.L., Nickerson M., Greenwood B.N., Fleshner M. Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 2005, 135:1295-1307.
90. Johnston I.N., Milligan E.D., Wieseler-Frank J., et al. A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. Journal of Neuroscience 2004, 24:7353-7365.
91. Kaestner F., Hettich M., Peters M., et al. Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. Journal of Affective Disorders 2005, 87:305-311.
92. Kavelaars A. Regulated expression of alpha-1 adrenergic receptors in the immune system. Brain, Behavior, and Immunity 2002, 16:799-807.
93. Kawakami N., Tanigawa T., Araki S., Nakata A., Sakurai S., Yokoyama K., Morita Y. Effects of job strain on helper-inducer (CD4+CD29+) and suppressor-inducer (CD4+CD45RA+) T cells in Japanese blue-collar workers. Psychotherapy and Psychosomatics 1997, 66:192-198.
94. Kemeny M.E., Gruenewald T.L. Affect, cognition, the immune system and health. Progress in Brain Research 2000, 122:291-308.
95. Kendler K.S., Gardner C.O., Prescott C.A. Toward a comprehensive developmental model for major depression in women. American Journal of Psychiatry 2002, 159:1133-1145.
96. Kenis G., Maes M. Effects of antidepressants on the production of cytokines. International Journal of Neuropsychopharmacology 2002, 5:401-412.
97. Kent S., Bluthe R.M., Kelley K.W., Dantzer R. Sickness behavior as a new target for drug development. Trends in Pharmacological Sciences 1992, 13:24-28.
98. Kiecolt-Glaser J.K., Belury M.A., Porter K., Beversdorf D.Q., Lemeshow S., Glaser R. Depressive symptoms, omega-6: Omega-3 fatty acids, and inflammation in older adults. Psychosomatic Medicine 2007, 69:217-224.
99. Kiecolt-Glaser J.K., Glaser R., Gravenstein S., Malarkey W.B., Sheridan J. Chronic stress alters the immune response to influenza virus vaccine in older adults. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:3043-3047.
100. Kirschbaum C., Pirke K.M., Hellhammer D.H. The 'trier social stress test' - a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993, 28:76-81.
101. Kling M.A., Alesci S., Csako G., et al. Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A. Biological Psychiatry 2007, 62:309-313.
102. Klokker M., Secher N.H., Madsen P., Pedersen M., Pedersen B.K. Adrenergic beta 1-and beta 1 + 2-receptor blockade suppress the natural killer cell response to head-up tilt in humans. Journal of Applied Physiology 1997, 83:1492-1498.
103. Kohm A.P., Sanders V.M. Norepinephrine: A messenger from the brain to the immune system. Immunology Today 2000, 21:539-542.
104. Koo J.W., Duman R.S. IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:751-756.
105. Kozak W., Kluger M.J., Tesfaigzi J., Kozak A., Mayfield K.P., Wachulec M., Dokladny K. Molecular mechanisms of fever and endogenous antipyresis. Annals of the New York Academy of Sciences 2000, 917:121-134.
106. Kubera M., Basta-Kaim A., Holan V., et al. Effect of mild chronic stress, as a model of depression, on the immunoreactivity of C57BL/6 mice. International Journal of Immunopharmacology 1998, 20:781-789.
107. Kudielka B.M., Kirschbaum C. Sex differences in HPA axis responses to stress: A review. Biological Psychology 2005, 69:113-132.
108. Labeur M.S., Arzt E., Wiegers G.J., Holsboer F., Reul J.M. Long-term intracerebroventricular corticotropin-releasing hormone administration induces distinct changes in rat splenocyte activation and cytokine expression. Endocrinology 1995, 136:2678-2688.
109. Laudenslager M.L., Ryan S.M., Drugan R.C., Hyson R.L., Maier S.F. Coping and immunosuppression: Inescapable but not escapable shock suppresses lymphocyte proliferation. Science 1983, 221:568-570.
110. Leserman J., Petitto J.M., Golden R.N., et al. Impact of stressful life events, depression, social support, coping, and cortisol on progression to AIDS. American Journal of Psychiatry 2000, 157:1221-1228.
111. Leu S.J., Singh V.K. Stimulation of interleukin-6 production by corticotropin-releasing factor. Cellular Immunology 1992, 143:220-227.
112. Levenson C.W. Zinc: The new antidepressant?. Nutrition Reviews 2006, 64:39-42.
113. Levine J., Barak Y., Chengappa K.N., Rapoport A., Rebey M., Barak V. Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 1999, 40:171-176.
114. Lewis-Tuffin L.J., Cidlowski J.A. The physiology of human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance. Annals of the New York Academy of Sciences 2006, 1069:1-9.
115. Li J., Cowden L.G., King J.D., et al. Effects of chronic stress and interleukin-10 gene polymorphisms on antibody response to tetanus vaccine in family caregivers of patients with Alzheimer's disease. Psychosomatic Medicine 2007, 69:551-559.
116. Lloyd A., Hickie I., Hickie C., Dwyer J., Wakefield D. Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression. Clinical and Experimental Immunology 1992, 87:76-79.
117. Lutgendorf S.K., Sood A.K., Anderson B., et al. Social support, psychological distress, and natural killer cell activity in ovarian cancer. Journal of Clinical Oncology 2005, 23:7105-7113.
118. Maes M. Major depression and activation of the inflammatory response system. Advances in Experimental Medicine and Biology 1999, 461:25-46.
119. Maes M., Meltzer H.Y., Stevens W., Calabrese J., Cosyns P. Natural killer cell activity in major depression: Relation to circulating natural killer cells, cellular indices of the immune response, and depressive phenomenology. Progress in Neuropsychopharmacology and Biological Psychiatry 1994, 18:717-730.
120. Maes M., Scharpe S., Meltzer H.Y., Bosmans E., Suy E., Calabrese J., Cosyns P. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Research 1993, 49:11-27.
121. Maes M., Scharpe S., Verkerk R., et al. Seasonal variation in plasma L-tryptophan availability in healthy volunteers. Relationships to violent suicide occurrence. Archives of General Psychiatry 1995, 52:937-946.
122. Maes M., Stevens W., Peeters D., et al. A study on the blunted natural killer cell activity in severely depressed patients. Life Sciences 1992, 50:505-513.
123. Marsland A.L., Bachen E.A., Cohen S., Rabin B., Manuck S.B. Stress, immune reactivity and susceptibility to infectious disease. Physiology and Behavior 2002, 77:711-716.
124. Martin J.T. Sexual dimorphism in immune function: The role of prenatal exposure to androgens and estrogens. European Journal of Pharmacology 2000, 405:251-261.
125. Marucha P.T., Kiecolt-Glaser J.K., Favagehi M. Mucosal wound healing is impaired by examination stress. Psychosomatic Medicine 1998, 60:362-365.
126. Mazzeo R.S., Donovan D., Fleshner M., Butterfield G.E., Zamudio S., Wolfel E.E., Moore L.G. Interleukin-6 response to exercise and high-altitude exposure: Influence of alpha-adrenergic blockade. Journal of Applied Physiology 2001, 91:2143-2149.
127. McEwen B.S., Biron C.A., Brunson K.W., et al. The role of adrenocorticoids as modulators of immune function in health and disease: Neural, endocrine and immune interactions. Brain Research - Brain Research Reviews 1997, 23:79-133.
128. McKay L.I., Cidlowski J.A. Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: Mechanisms of mutual antagonism. Molecular Endocrinology 1998, 12:45-56.
129. Millar D.B., Thomas J.R., Pacheco N.D., Rollwagen F.M. Natural killer cell cytotoxicity and T-cell proliferation is enhanced by avoidance behavior. Brain, Behavior, and Immunity 1993, 7:144-153.
130. Miller A.H., Pariante C.M., Pearce B.D. Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression. Advances in Experimental Medicine and Biology 1999, 461:107-116.
131. Miller G.E., Stetler C.A., Carney R.M., Freedland K.E., Banks W.A. Clinical depression and inflammatory risk markers for coronary heart disease. American Journal of Cardiology 2002, 90:1279-1283.
132. Miller A.H., Vogt G., Pearce B.D. The phosphodiesterase type 4 inhibitor, rolipram, enhances glucocorticoid receptor function. Neuropsychopharmacology 2002, 27:939-948.
133. Miyazaki T., Ishikawa T., Nakata A., et al. Association between perceived social support and Th1 dominance. Biological Psychology 2005, 70:30-37.
134. Muller N., Schwarz M.J., Dehning S., et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: Results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Molecular Psychiatry 2006, 11:680-684.
135. Musselman D.L., Lawson D.H., Gumnick J.F., et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. (see comments). New England Journal of Medicine 2001, 344:961-966.
136. Musselman D.L., Miller A.H., Porter M.R., et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: Preliminary findings. American Journal of Psychiatry 2001, 158:1252-1257.
137. Nadeau S., Rivest S. Glucocorticoids play a fundamental role in protecting the brain during innate immune response. Journal of Neuroscience 2003, 23:5536-5544.
138. Nadjar A., Bluthe R.M., May M.J., Dantzer R., Parnet P. Inactivation of the cerebral NFkappaB pathway inhibits interleukin-1beta-induced sickness behavior and c-Fos expression in various brain nuclei. Neuropsychopharmacology 2005, 30:1492-1499.
139. Nakata A., Araki S., Tanigawa T., et al. Decrease of suppressor-inducer (CD4+ CD45RA) T lymphocytes and increase of serum immunoglobulin G due to perceived job stress in Japanese nuclear electric power plant workers. Journal of Occupational and Environmental Medicine 2000, 42:143-150.
140. NaliboffB.D., Solomon G.F., Gilmore S.L., Fahey J.L., Benton D., Pine J. Rapid changes in cellular immunity following a confrontational role-play stressor. Brain, Behavior, and Immunity 1995, 9:207-219.
141. Nance D.M., Sanders V.M. Autonomic innervation and regulation of the immune system (1987-2007). Brain, Behavior, and Immunity 2007, 21:736-745.
142. NemeroffC.B. The corticotropin-releasing factor (CRF) hypothesis of depression: New findings and new directions. (see comment). Molecular Psychiatry 1996, 1:336-342.
143. Nguyen K.T., Deak T., Owens S.M., Kohno T., Fleshner M., Watkins L.R., Maier S.F. Exposure to acute stress induces brain interleukin-1beta protein in the rat. Journal of Neuroscience 1998, 18:2239-2246.
144. Nishioka T., Kurokawa H., Takao T., Kumon Y., Nishiya K., Hashimoto K. Differential changes of corticotropin releasing hormone (CRH) concentrations in plasma and synovial fluids of patients with rheumatoid arthritis (RA). Endocrine Journal 1996, 43:241-247.
145. O'Connor K.A., Johnson J.D., Hansen M.K., WieselerFrank J.L., Maksimova E., Watkins L.R., Maier S.F. Peripheral and central proinflammatory cytokine response to a severe acute stressor. Brain Research 2003, 991:123-132.
146. Obuchowicz E., Kowalski J., Labuzek K., Krysiak R., Pendzich J., Herman Z.S. Amitriptyline and nortriptyline inhibit interleukin-1 release by rat mixed glial and microglial cell cultures. International Journal of Neuropsychopharmacology 2006, 9:27-35.
147. Pace T.W., Hu F., Miller A.H. Cytokine-effects on glucocorticoid receptor function: Relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain, Behavior, and Immunity 2007, 21:9-19.
148. Pace T.W., Mletzko T.C., Alagbe O., Musselman D.L., NemeroffC.B., Miller A.H. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. American Journal of Psychiatry 2006, 163:1630-1633.
149. Paez Pereda M., Sauer J., Perez Castro C., Finkielman S., Stalla G.K., Holsboer F., Arzt E. Corticotropin-releasing hormone differentially modulates the interleukin-1 system according to the level of monocyte activation by endotoxin. Endocrinology 1995, 136:5504-5510.
150. Pariante C.M. Glucocorticoid receptor function in vitro in patients with major depression. Stress 2004, 7:209-219.
151. Pariante C.M. The role of multi-drug resistance P-glycoprotein in glucocorticoid function: Studies in animals and relevance in humans. European Journal of Pharmacology 2008, 583:263-271.
152. Pariante C.M., Carpiniello B., Orru M.G., et al. Chronic caregiving stress alters peripheral blood immune parameters: The role of age and severity of stress. Psychotherapy and Psychosomatics 1997, 66:199-207.
153. Pariante C.M., MakoffA., Lovestone S., Feroli S., Heyden A., Miller A.H., Kerwin R.W. Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters. British Journal of Pharmacology 2001, 134:1335-1343.
154. Pariante C.M., Miller A.H. Glucocorticoid receptors in major depression: Relevance to pathophysiology and treatment. Biological Psychiatry 2001, 49:391-404.
155. Pariante C.M., Pearce B.D., Pisell T.L., Owens M.J., Miller A.H. Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine. Molecular Pharmacology 1997, 52:571-581.
156. Pariante C.M., Pearce B.D., Pisell T.L., Sanchez C.I., Po C., Su C., Miller A.H. The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology 1999, 140:4359-4366.
157. Pavlov V.A., Tracey K.J. Neural regulators of innate immune responses and inflammation. Cellular and Molecular Life Sciences 2004, 61:2322-2331.
158. Pavlov V.A., Tracey K.J. The cholinergic anti-inflammatory pathway. Brain, Behavior, and Immunity 2005, 19:493-499.
159. Penza K.M., Heim C., NemeroffC.B. Neurobiological effects of childhood abuse: Implications for the pathophysiology of depression and anxiety. Archives of Women's Mental Health 2003, 6:15-22.
160. Peters M.L., Godaert G.L., Ballieux R.E., et al. Immune responses to experimental stress: Effects of mental effort and uncontrollability. Psychosomatic Medicine 1999, 61:513-524.
161. Quan N., Avitsur R., Stark J.L., et al. Social stress increases the susceptibility to endotoxic shock. Journal of Neuroimmunology 2001, 115:36-45.
162. Quan N., Banks W.A. Brain-immune communication pathways. Brain, Behavior, and Immunity 2007, 21:727-735.
163. Quan N., Whiteside M., Herkenham M. Time course and localization patterns of interleukin-1beta messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience 1998, 83:281-293.
164. Rabin B. Stress, Immune Function, and Health: The Connection 1999, Wiley, New York.
165. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: Inflammation and the pathogenesis of major depression. Trends in Immunology 2006, 27:24-31.
166. Raison C.L., Miller A.H. When not enough is too much: The role of insufficient glucocorticoid signaling in the pathophysiology of
167. Rhen T., Cidlowski J.A. Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. New England Journal of Medicine 2005, 353:1711-1723.
168. Richaud-Patin Y., Vega-Boada F., Vidaller A., Llorente L. Multidrug resistance-1 (MDR-1) in autoimmune disorders IV. P-glycoprotein overfunction in lymphocytes from myasthenia gravis patients. Biomedicine and Pharmacotherapy 2004, 58:320-324.
169. Rivest S. Molecular insights on the cerebral innate immune system. Brain, Behavior, and Immunity 2003, 17:13-19.
170. Rogatsky I., Ivashkiv L.B. Glucocorticoid modulation of cytokine signaling. Tissue Antigens 2006, 68:1-12.
171. Rogers C.J., Brissette-Storkus C.S., Chambers W.H., Cameron J.L. Acute stress impairs NK cell adhesion and cytotoxicity through CD2, but not LFA-1. Journal of Neuroimmunology 1999, 99:230-241.
172. Rood Y.R., Bogaards M., Goulmy E., Houwelingen H.C. The effects of stress and relaxation on the in vitro immune response in man: A meta-analytic study. Journal of Behavioral Medicine 1993, 16:163-181.
173. Roy S., Wang J., Kelschenbach J., Koodie L., Martin J. Modulation of immune function by morphine: Implications for susceptibility to infection. Journal of Neuroimmune Pharmacology 2006, 1:77-89.
174. Ruzek M.C., Pearce B.D., Miller A.H., Biron C.A. Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection. Journal of Immunology 1999, 162:3527-3533.
175. Sanchez M.M., Alagbe O., Felger J.C., et al. Activated p38 MAPK is associated with decreased CSF 5-HIAA and increased maternal rejection during infancy in rhesus monkeys. Molecular Psychiatry 2007, 12:895-897.
176. Sapolsky R.M., Romero L.M., Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrine Reviews 2000, 21:55-89.
177. Saul A.N., Oberyszyn T.M., Daugherty C., et al. Chronic stress and susceptibility to skin cancer. Journal of the National Cancer Institute 2005, 97:1760-1767.
178. Schulte H.M., Bamberger C.M., Elsen H., Herrmann G., Bamberger A.M., Barth J. Systemic interleukin-1 alpha and interleukin-2 secretion in response to acute stress and to corticotropin-releasing hormone in humans. European Journal of Clinical Investigation 1994, 24:773-777.
179. Segerstrom S.C., Schipper L.J., Greenberg R.N. Caregiving, repetitive thought, and immune response to vaccination in older adults. Brain, Behavior, and Immunity 2008, 22:744-752.
180. Shavit Y., Lewis J.W., Terman G.W., Gale R.P., Liebeskind J.C. Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science 1984, 223:188-190.
181. Silberman D.M., Wald M.R., Genaro A.M. Acute and chronic stress exert opposing effects on antibody responses associated with changes in stress hormone regulation of T-lymphocyte reactivity. Journal of Neuroimmunology 2003, 144:53-60.
182. Silverman M.N., Macdougall M.G., Hu F., Pace T.W., Raison C.L., Miller A.H. Endogenous glucocorticoids protect against TNF-alpha-induced increases in anxiety-like behavior in virally infected mice. Molecular Psychiatry 2007, 12:408-417.
183. Silverman M.N., Pearce B.D., Biron C.A., Miller A.H. Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunology 2005, 18:41-78.
184. Sloan R.P., McCreath H., Tracey K.J., Sidney S., Liu K., Seeman T. RR interval variability is inversely related to inflammatory markers: The CARDIA study. Molecular Medicine 2007, 13:178-184.
185. Smith R.S. The macrophage theory of depression. Medical Hypotheses 1991, 35:298-306. erratum appears in Medical Hypotheses 1991 Oct; 36(2): 178.
186. Smith E.M., Gregg M., Hashemi F., Schott L., Hughes T.K. Corticotropin releasing factor (CRF) activation of NF-kappaB-directed transcription in leukocytes. Cellular and Molecular Neurobiology 2006, 26:1021-1036.
187. Sorrells S.F., Sapolsky R.M. An inflammatory review of glucocorticoid actions in the CNS. Brain, Behavior, and Immunity 2007, 21:259-272.
188. Spiegel D., Bloom J.R., Kraemer H.C., Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. (see comments). Lancet 1989, 2:888-891.
189. Spiegel D., Butler L.D., Giese-Davis J., et al. Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: A randomized prospective trial. Cancer 2007, 110:1130-1138.
190. Stark J.L., Avitsur R., Padgett D.A., Campbell K.A., Beck F.M., Sheridan J.F. Social stress induces glucocorticoid resistance in macrophages. AJP - Regulatory, Integrative and Comparative Physiology 2001, 280:R1799-R1805.
191. Stenzel-Poore M.P., Duncan J.E., Rittenberg M.B., Bakke A.C., Heinrichs S.C. CRH overproduction in transgenic mice: Behavioral and immune system modulation. Annals of the New York Academy of Sciences 1996, 780:36-48.
192. Steptoe A., Hamer M., Chida Y. The effect of acute psychological stress on circulating inflammatory factors in humans: A review and meta-analysis. Brain, Behavior, and Immunity 2007, 21:901-912.
193. Sternberg E.M., Hill J.M., Chrousos G.P., Kamilaris T., Listwak S.J., Gold P.W., Wilder R.L. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proceedings of the National Academy of Sciences of the United States of America 1989, 86:2374-2378.
194. Szatmary Z., Garabedian M.J., Vilcek J. Inhibition of glucocorticoid receptor-mediated transcriptional activation by p38 mitogen-activated protein (MAP) kinase. Journal of Biological Chemistry 2004, 279:43708-43715.
195. Thomas A.J., Davis S., Morris C., Jackson E., Harrison R., O'Brien J.T. Increase in interleukin-1beta in late-life depression. American Journal of Psychiatry 2005, 162:175-177.
196. Thornton L.M., Andersen B.L., Crespin T.R., Carson W.E. Individual trajectories in stress covary with immunity during recovery from cancer diagnosis and treatments. Brain, Behavior, and Immunity 2007, 21:185-194.
197. Tracey K.J. The inflammatory reflex. Nature 2002, 420:853-859.
198. Turnbull A.V., Rivier C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: Actions and mechanisms of action. Physiological Reviews 1999, 79:1-71.
199. Tyring S., Gottlieb A., Papp K., et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: Double-blind placebo-controlled randomised phase III trial. (see comment). Lancet 2006, 367:29-35.
200. Uchino B.N. Social support and health: A review of physiological processes potentially underlying links to disease outcomes. Journal of Behavioral Medicine 2006, 29:377-387.
201. Vallejo R., deLeon-Casasola O., Benyamin R. Opioid therapy and immunosuppression: A review. American Journal of Therapeutics 2004, 11:354-365.
202. Vedhara K., Nott K. The assessment of the emotional and immunological consequences of examination stress. Journal of Behavioral Medicine 1996, 19:467-478.
203. Viswanathan K., Daugherty C., Dhabhar F.S. Stress as an endogenous adjuvant: Augmentation of the immunization phase of cell-mediated immunity. International Immunology 2005, 17:1059-1069.
204. Viswanathan K., Dhabhar F.S. Stress-induced enhancement of leukocyte trafficking into sites of surgery or immune activation. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:5808-5813.
205. Vitkovic L., Konsman J.P., Bockaert J., Dantzer R., Homburger V., Jacque C. Cytokine signals propagate through the brain. Molecular Psychiatry. Molecular Psychiatry 2001, 6(2):249-615. erratum appears in, Mar.
206. von Kanel R., Dimsdale J.E., Mills P.J., Ancoli-Israel S., Patterson T.L., Mausbach B.T., Grant I. Effect of Alzheimer caregiving stress and age on frailty markers interleukin-6, C-reactive protein, and D-dimer. Journals of Gerontology, Series A 2006, 61:963-969.
207. Wang X., Wu H., Lakdawala V.S., Hu F., Hanson N.D., Miller A.H. Inhibition of Jun N-terminal kinase (JNK) enhances glucocorticoid receptor-mediated function in mouse hippocampal HT22 cells. Neuropsychopharmacology 2005, 30:242-249.
208. Wang X., Wu H., Miller A.H. Interleukin-1 alpha-induced activation of p38 mitogen-activated kinase inhibits glucocorticoid receptor function. Molecular Psychiatry 2004, 9:65-75.
209. Watkins L.R., Wiertelak E.P., Goehler L.E., et al. Neurocircuitry of illness-induced hyperalgesia. Brain Research 1994, 639:283-299.
210. Webster J.C., Oakley R.H., Jewell C.M., Cidlowski J.A. Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: A mechanism for the generation of glucocorticoid resistance. Proceedings of the National Academy of Sciences United States of America 2001, 98:6865-6870.
211. Weisse C.S., Pato C.N., McAllister C.G., Littman R., Breier A., Paul S.M., Baum A. Differential effects of controllable and uncontrollable acute stress on lymphocyte proliferation and leukocyte percentages in humans. Brain, Behavior, and Immunity 1990, 4:339-351.
212. Willerson J.T., Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 2004, 109:II2-II10.
213. Xu Y., Ku B.S., Yao H.Y., Lin Y.H., Ma X., Zhang Y.H., Li X.J. Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacology, Biochemistry and Behavior 2005, 82:200-206.
214. Xu Y., Ku B.S., Yao H.Y., Lin Y.H., Ma X., Zhang Y.H., Li X.J. The effects of curcumin on depressive-like behaviors in mice. European Journal of Pharmacology 2005, 518:40-46.
215. Yirmiya R., Pollak Y., Morag M., et al. Illness, cytokines, and depression. Annals of the New York Academy of Sciences 2000, 917:478-487.
216. Yu C.Y., Whitacre C.C. Sex, MHC and complement C4 in autoimmune diseases. Trends in Immunology 2004, 25:694-699.
217. Zaharia M.D., Ravindran A.V., Griffiths J., Merali Z., Anisman H. Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features. Journal of Affective Disorders 2000, 58:1-10.
218. Zalcman S., Henderson N., Richter M., Anisman H. Age-related enhancement and suppression of a T-cell-dependent antibody response following stressor exposure. Behavioral Neuroscience 1991, 105:669-676.
219. Zhu C.B., Carneiro A.M., Dostmann W.R., Hewlett W.A., Blakely R.D. p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. Journal of Biological Chemistry 2005, 280:15649-15658.
220. Zorrilla E.P., Luborsky L., McKay J.R., et al. The relationship of depression and stressors to immunological assays: A meta-analytic review. Brain, Behavior, and Immunity 2001, 15:199-226.